Protagonist Therapeutics, Inc. · NASDAQ:PTGX

BVF PARTNERS L P/IL's stake in Protagonist Therapeutics, Inc. fell to 4.10% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

BVF PARTNERS L P/IL's stake in Protagonist Therapeutics, Inc. fell to 4.10%, 2,560,916 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
4.10%
Shares
2,560,916
Intent
Passive
What changed
Fell below 5%
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P2.10%1,323,333
BVF I GP LLC2.10%1,323,333
BIOTECHNOLOGY VALUE FUND II LP1.70%1,045,774
BVF II GP LLC1.70%1,045,774
Biotechnology Value Trading Fund OS LP0.20%140,917
BVF Partners OS Ltd.0.20%140,917
BVF GP HOLDINGS LLC3.80%2,369,107
BVF PARTNERS L P/IL4.10%2,560,916
BVF INC/IL4.10%2,560,916
LAMPERT MARK N4.10%2,560,916

Source

View original at SEC

Related